Background: Chronic fetal hypoxia is commonly associated with increased risk of premature delivery and thus also to antenatal exposure to dexamethasone. Though the use of glucocorticoids in premature birth has been well studied, their effect on fetal lungs that have experienced chronic hypoxia is yet to be determined.
Methods: At 100d gestation (term, 145d) ewes were randomly assigned to Normoxia Saline (21% O 2 ; 2 mL vehicle), Hypoxia Saline (10-11% O 2 ), Normoxia Dexamethasone (2 i. m.,12 mg injection of dexamethasone 24 h apart at 115 and 116d) or Hypoxia Dexamethasone groups. Chronic hypoxia for 1 month was induced in isobaric chambers. At 138d gestation animals were humanely killed (sodium pentobarbitone). Fetal lungs were frozen in liquid N2 for total RNA extraction. qRT-PCR determined the expression of genes involved in surfactant maturation, hypoxia signalling and glucocorticoid regulation. Data were analysed by Two-way ANOVA.
Results: Dexamethasone increased the expression of genes involved in surfactant maturation in fetal lungs from both normoxic and hypoxic pregnancy (SFTP-B, SFTP-C and ABCA3). Fetal lungs from hypoxic pregnancy showed increased expression of the antioxidant GPX, while decreased expression of HSD11B2, involved in the conversion of active cortisol to inactive cortisone. Both chronic hypoxia and dexamethasone increased the expression of HIF3A.
Conclusions: We show that dexamethasone promotes surfactant maturation in the late gestation fetal lung regardless of maternal oxygen status. The interplay between chronic hypoxia and glucocorticoid treatment mediating additional effects on hypoxia signalling and altered cortisol conversion warrants further investigation to determine if these changes have a positive or negative impact on lung development. Case: We report a case of fetus diagnosed with a cervical teratoma at 26 weeks gestation leading to hypoplastic left lung and congestive cardiac failure.
A CASE OF CONGENITAL CERVICAL TERATOMA RESULTING IN HYDROPS FETALIS AND FETAL DEATH
A 35-year-old G4P3 presented in the first trimester for antenatal care. She had a low risk CFTS and normal morphology ultrasound at 19 + 5 weeks. Insulin was commenced at 20 + 5 weeks for early diagnosis of gestational diabetes. A subsequent growth ultrasound at 26 weeks identified a fetal neck mass. A tertiary ultrasound revealed the fetal neck in a fixed extended position with a large, highly vascularized anterior neck mass (82mmx81mmx59mm) and fetal hydrops with extensive skin edema, pleural effusions, ascites, polyhydramnios, and likely impaired cardiac function.
Discussion: Perinatal death can occur due to local mechanical effects and/or high output cardiac failure. Compression of the trachea can result in respiratory compromise. Cervical teratomas also have a known association with pulmonary hypoplasia although the predictive criteria remain unknown. High output cardiac failure due to tumor-mediated arteriovenous shunt and/or compromised central venous return can also cause perinatal death. In this fetus the left lung is hypoplastic while the severe hydrops fetalis and villous hydrops in the placenta are evidence of severe congestive cardiac failure. Cervical teratomas are considered sporadic accidents of organogenesis with a low risk of reoccurrence.
